Dr. Reddy’s launches new tablets

M. Somasekhar Updated - March 13, 2018 at 10:43 AM.

Dr. Reddy’s Laboratories has launched Montelukast Sodium tablets in 10 mg and Montelukast Sodium Chewable tablets (4 mg & 5 mg).

The drug is a bioequivalent generic version of SINGULAIR® tablets and Chewable tablets.

The Hyderabad-based pharma major launched it in the US market on August 6, following approval by the United States Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA).

The Singular tablets and Chewable tablets brand had US sales of approximately $3.6 billion and $1.14 billion, respectively for the most recent 12 months ended March 31, 2012, according to IMS Health.

Dr. Reddy’s Montelukast Sodium tablets in 10 mg and Montelukast Sodium Chewable tablets in 4 mg and 5 mg are available in bottle counts of 30 and 90, a company release said.

Somasekhar.m@thehindu.co.in

Published on August 7, 2012 12:43